**Question:** Poor prognostic factor for ALL is

A. High white blood cell count
B. Age greater than 60 years
C. Severe thrombocytopenia
D. Extramedullary involvement

**Correct Answer:** B. Age greater than 60 years

**Core Concept:** Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the bone marrow and blood. The disease is characterized by the rapid proliferation of immature lymphocytes, leading to the overproduction of white blood cells. The prognosis of ALL is influenced by several factors, including age, presenting symptoms, and laboratory findings.

**Why the Correct Answer is Right:** Age is a significant factor in ALL prognosis because older patients often have more severe complications and a less favorable response to treatment. In adults, the disease presents differently and tends to be more aggressive, with higher white blood cell counts and less favorable outcomes compared to pediatric patients. As a result, age greater than 60 years is considered a poor prognostic factor for ALL.

**Why Each Wrong Option is Incorrect:**

A. High white blood cell count (WBC) is a feature of ALL but not a poor prognostic factor. While a high WBC count indicates a more advanced stage of the disease, it is not the sole determinant of prognosis.

B. Age less than 60 years is considered a favorable prognostic factor for ALL. Older patients have more severe complications, a higher risk of relapse, and a lower overall survival rate.

C. Severe thrombocytopenia (low platelet count) might indicate a poorer prognosis due to increased risk of bleeding complications and impaired immune function. However, it is not the sole prognostic factor, as other factors play a significant role.

D. Extramedullary involvement (EMI) refers to the spread of ALL outside the bone marrow, which is generally associated with an unfavorable prognosis. However, EMI is not the sole poor prognostic factor, as several other factors contribute to determining the overall prognosis of ALL.

**Clinical Pearl:** A thorough assessment of ALL patients involves considering multiple factors, including age, WBC count, platelet count, and the presence of extramedullary involvement. While each of these factors may contribute to overall prognosis, they are not the sole determinants. A comprehensive evaluation of a patient's clinical presentation, laboratory findings, and treatment response will guide the assessment of prognosis and treatment strategy for ALL patients.